World's top Pharmaceuticals stocks
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $731.81bn | 69.47 | 0.61% |
NOVO BNovo Nordisk A/S | DKK3.99tn | 45.37 | 1.04% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $372.17bn | 16.58 | 3.08% |
MRKMerck & Co | $332.28bn | 57.1 | 2.29% |
ABBVAbbvie | $293.88bn | 32.88 | 3.6% |
AZNAstraZeneca | £187.73bn | 49.18 | 1.88% |
ROGRoche Holding AG | CH₣189.03bn | 13.18 | 4.05% |
RORoche Holding AG | CH₣189.03bn | 14.35 | 3.72% |
NOVNNovartis AG | CH₣182.68bn | 17.94 | 3.82% |
AMGNAmgen | $167.62bn | 44.38 | 2.77% |
PFEPfizer | $162.29bn | 10.21 | 5.76% |
SANSanofi SA | €111.58bn | 16.88 | 4.22% |
GSKGSK | £73.57bn | 14.05 | 3.32% |
CSLCSL | AU$135.27bn | 35.31 | 1.37% |
CELG RTBristol-Myers Squibb Co | $89.25bn | 0.01 | 4162.16% |
BMYBristol-Myers Squibb Co | $89.25bn | 11.74 | 5.25% |
GILDGilead Sciences | $84.37bn | 12.07 | 4.46% |
ZTSZoetis | $79.42bn | 33.22 | 0.89% |
MRKMerck KGaA | €72.69bn | 23.19 | 1.32% |